BEIJING: A Chinese hospital specializing in cardiovascular care has successfully implemented a radiation-free percutaneous intervention method for treating heart disease.
This innovative treatment, developed by Fuwai Hospital under the Chinese Academy of Medical Sciences (CAMS), uses ultrasound guidance to deliver instruments from the peripheral blood vessels to the heart, minimizing invasiveness.
The procedure eliminates the need for surgery and radiation, allowing patients to remain awake during treatment. It is suitable for a wide range of patients, including pregnant women, those with allergies, and cancer patients. The hospital notes that the technical complexity of the procedure has been reduced, as it does not require costly imported equipment.
This advancement is expected to enhance primary medical services, making effective heart disease treatment more accessible to outpatients, particularly in regions with limited medical resources. The treatment method has also received funding from the United Nations.
Fuwai Hospital has developed over 17 new treatments for various cardiovascular conditions, such as congenital heart disease, valvular disease, and arrhythmia, resulting in 65 patents. Furthermore, the hospital has created a series of therapeutic instruments, including an ultrasonic catheter and a surgical robot, with 23 of these available both in China and internationally.
Medical teams from Fuwai Hospital have been invited to perform surgeries and share Chinese treatment solutions in more than 30 countries, including France, Germany, Canada, Russia, and Kenya.
